BRAVE ASSET MANAGEMENT INC

Position in BMY — Bristol Myers Squibb Co

CIK 1085867 Summit, NJ

Position in BMY

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$276,576

-$35,165 QoQ

Shares Held

4,800

-6.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#1,929

of 2,506 holders

Holding Since

Dec 2020

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRAVE ASSET MANAGEMENT INC holds $7,789,351 across 6 Drug Manufacturers - General names. BMY ranks #6 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	8,712	$2,212,586
2	LLY	ELI LILLY & Co	1,737	$2,083,410
3	MRK	Merck & Co., Inc.	12,299	$1,580,421
4	AMGN	Amgen Inc	2,940	$1,064,632
5	ABBV	AbbVie Inc.	2,272	$571,726
6	BMY	Bristol Myers Squibb Co This page	4,800	$276,576

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$276,576	4,800	-6.6%	Shares	Sole	2026-07-08
2026-03-31	$311,741	5,140	+16.8%	Shares	Sole	2026-04-17
2025-12-31	$237,336	4,400	0.0%	Shares	Sole	2026-01-08
2025-06-30	$203,676	4,400	-22.1%	Shares	Sole	2025-07-16
2025-03-31	$344,593	5,650	-11.7%	Shares	Sole	2025-04-10
2024-12-31	$361,984	6,400	0.0%	Shares	Sole	2025-01-14
2024-09-30	$331,136	6,400	+75.9%	Shares	Sole	2024-10-10
2023-06-30	$232,714	3,639	+2.0%	Shares	Sole	2023-07-24
2023-03-31	$247,367	3,569	-2.5%	Shares	Sole	2023-04-12
2022-12-31	$263,265	3,659	0.0%	Shares	Sole	2023-01-20
2022-09-30	$260,118	3,659	0.0%	Shares	Sole	2022-10-13
2022-06-30	$281,743	3,659	0.0%	Shares	Sole	2022-07-15
2022-03-31	$267,216	3,659	0.0%	Shares	Sole	2022-04-22
2021-12-31	$228,138	3,659	0.0%	Shares	Sole	2022-01-21
2021-09-30	$216,503	3,659	-2.7%	Shares	Sole	2021-11-02
2021-06-30	$251,176	3,759	0.0%	Shares	Sole	2021-07-27
2021-03-31	$237,305	3,759	-7.4%	Shares	Sole	2021-04-26
2020-12-31	$251,779	4,059	—	Shares	Sole	2021-01-27
No filing history on record for this holder in this stock.